Completed Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. NCT04965649 Conditions BCR-ABL Positive Acute Myeloid Leukemia, Chronic Leukemia, Hematologic Diseases, +6 more Locations CHU de Nîmes — Nîmes, Gard, France View Trial Details
